Cargando…

Anticipating New Treatments for Cystic Fibrosis: A Global Survey of Researchers

Cystic fibrosis is a life-threatening disease that affects at least 100,000 people worldwide. It is caused by a defect in the cystic fibrosis transmembrane regulator (CFTR) gene and presently, 360 CFTR-causing mutations have been identified. Since the discovery of the CFTR gene, the expectation of d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabral, Bernardo, Terlizzi, Vito, Laselva, Onofrio, Conte Filho, Carlos, Mota, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911007/ https://www.ncbi.nlm.nih.gov/pubmed/35268374 http://dx.doi.org/10.3390/jcm11051283

Ejemplares similares

Modulator Therapy in Cystic Fibrosis Patients with cis Variants in F508del Complex Allele: A Short-Term Observational Case Series
por: Terlizzi, Vito, et al.
Publicado: (2022)

Elexacaftor/Tezacaftor/Ivacaftor Accelerates Wound Repair in Cystic Fibrosis Airway Epithelium
por: Laselva, Onofrio, et al.
Publicado: (2022)

Editorial: Mechanisms of Novel Drugs and Gene Modifiers in the Treatment of Cystic Fibrosis
por: Veit, Guido, et al.
Publicado: (2022)

Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis
por: Silva, Iris A. L., et al.
Publicado: (2022)

Activity of lumacaftor is not conserved in zebrafish Cftr bearing the major cystic fibrosis‐causing mutation
por: Laselva, Onofrio, et al.
Publicado: (2019)

Olive Leaf Extract (OLE) as a Novel Antioxidant That Ameliorates the Inflammatory Response in Cystic Fibrosis
por: Allegretta, Caterina, et al.
Publicado: (2023)

Auxological and Endocrinological Features in Children and Adolescents with Cystic Fibrosis
por: Ferrari, Vittorio, et al.
Publicado: (2022)

Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells
por: Laselva, Onofrio, et al.
Publicado: (2021)

Expert Opinions on the Most Promising Treatments and Vaccine Candidates for COVID-19: Global Cross-sectional Survey of Virus Researchers in the Early Months of the Pandemic
por: Cabral, Bernardo Pereira, et al.
Publicado: (2021)

Future of Artificial Intelligence Applications in Cancer Care: A Global Cross-Sectional Survey of Researchers
por: Cabral, Bernardo Pereira, et al.
Publicado: (2023)

G378X‐I148T CFTR variant: A new complex allele in a cystic fibrosis newborn with pancreatic insufficiency
por: Terlizzi, Vito, et al.
Publicado: (2022)

Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index
por: Terlizzi, Vito, et al.
Publicado: (2022)

Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
por: Chin, Stephanie, et al.
Publicado: (2019)

Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice
por: Terlizzi, Vito, et al.
Publicado: (2021)

Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells
por: Laselva, Onofrio, et al.
Publicado: (2022)

Comparison between Gibson–Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis
por: Dolce, Daniela, et al.
Publicado: (2023)

Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator
por: Laselva, Onofrio, et al.
Publicado: (2021)

Allele-Specific Prevention of Nonsense-Mediated Decay in Cystic Fibrosis Using Homology-Independent Genome Editing
por: Erwood, Steven, et al.
Publicado: (2020)

A protocol for identifying the binding sites of small molecules on the cystic fibrosis transmembrane conductance regulator (CFTR) protein
por: Laselva, Onofrio, et al.
Publicado: (2022)

Risk factors for severe COVID-19 in people with cystic fibrosis: A systematic review
por: Terlizzi, Vito, et al.
Publicado: (2022)

Stenotrophomonas maltophilia in people with Cystic Fibrosis: a systematic review of prevalence, risk factors and management
por: Terlizzi, Vito, et al.
Publicado: (2023)

Human Amniotic Mesenchymal Stem Cells and Fibroblasts Accelerate Wound Repair of Cystic Fibrosis Epithelium
por: Beccia, Elisa, et al.
Publicado: (2022)

Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series
por: Terlizzi, Vito, et al.
Publicado: (2022)

Concomitant Use of Elexacaftor/Tezacaftor/Ivacaftor and Etanercept in a Cystic Fibrosis Patient with Juvenile Idiopathic Arthritis
por: Orsini, Sara Immacolata, et al.
Publicado: (2023)

Global impact of bronchiectasis and cystic fibrosis
por: Redondo, Margarida, et al.
Publicado: (2016)

Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease
por: Giallongo, Alessandro, et al.
Publicado: (2023)

Early Effects of Elexacaftor-Tezacaftor-Ivacaftor Therapy on Magnetic Resonance Imaging in Patients with Cystic Fibrosis and Advanced Lung Disease
por: Macconi, Letizia, et al.
Publicado: (2022)

A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients
por: Jiang, Jia Xin, et al.
Publicado: (2021)

Elevated sweat chloride test: is it always cystic fibrosis?
por: Cimbalo, C., et al.
Publicado: (2021)

Elexacaftor–Tezacaftor–Ivacaftor Therapy for Cystic Fibrosis Patients with The F508del/Unknown Genotype
por: Comegna, Marika, et al.
Publicado: (2021)

Proteomics and Metabolomics for Cystic Fibrosis Research
por: Liessi, Nara, et al.
Publicado: (2020)

Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present
por: Botti, Matteo, et al.
Publicado: (2021)

Type 2 inflammation in cystic fibrosis: New insights
por: Manti, Sara, et al.
Publicado: (2022)

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
por: Lambiase, A., et al.
Publicado: (2011)

A Multicentre Italian Study on the Psychological Impact of an Inconclusive Cystic Fibrosis Diagnosis after Positive Neonatal Screening
por: Tosco, Antonella, et al.
Publicado: (2023)

Systematic review on fecal calprotectin in cystic fibrosis
por: Lazzarotto, Eduarda Sampaio, et al.
Publicado: (2022)

Clinical characteristics and outcome of SARS –CoV-2 infection in patients with cystic fibrosis managed at home
por: Terlizzi, V., et al.
Publicado: (2022)

Voice Disorder in Cystic Fibrosis Patients
por: Lourenço, Bruna Mendes, et al.
Publicado: (2014)

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)

Clinical and Genotypical Features of False-Negative Patients in 26 Years of Cystic Fibrosis Neonatal Screening in Tuscany, Italy
por: Taccetti, Giovanni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6a2rahho6ghfno8m481duje9cl